Pembrolizumab alone and pembrolizumab plus chemotherapy in previously treated, extrapulmonary poorly differentiated neuroendocrine carcinomas.
Nitya RajJennifer A ChanStephanie J WangRahul R AggarwalSusan CalabreseApril DeMoreLawrence FongJennifer GrabowskyThomas A HopeKanti Pallav KolliClaire K MulveyPamela N MunsterKimberly PerezSippy PunnDiane Reidy-LagunesSofia Von FedakLi ZhangEmily K BergslandPublished in: British journal of cancer (2023)
ClinicalTrials.gov NCT03136055.